Protocol summary

Study aim
Comparison of the effect of adding Sufentanil and Dexamethasone to Ropivacaine 0.1% in painless labor using epidural anesthesia.
Design
Clinical trial without control group, with parallel-groups, double-blind, randomized, phase 3 clinical trial on 104 patients. Randomization.com online software and block randomization method will be used for randomization.
Settings and conduct
In this study, the number of 104 term pregnant patients who are candidates for natural pain-free delivery in Taleghani Hospital in Arak city will be studied. Patients are randomly divided by the anesthesiologist into A and B groups. In both groups, the drugs used for the intervention are the same in terms of transparency and color, and the anesthesiologist labeled each of them A and B. The used syringes are also of the same shape, same color, and completely similar, and in order to comply with blinding, the volume of 10 cc is brought by the anesthetist so that they will not be able to identify the contents of the solution from their appearance. The patients and the intern responsible for evaluating the patients were not aware of the type of groups and therefore the plan will be implemented in a double-blind manner.
Participants/Inclusion and exclusion criteria
Inclusion criteria: term pregnancy, singleton pregnancy. Exclusion criteria: heart, lung, kidney and liver diseases, allergy to used drugs, coagulopathy, spinal deformity
Intervention groups
In the first intervention group, 8 mg of dexamethasone (Alborz Daru-Iran) which was increased to 10 cc with 0.1% ropivacaine (Darman Yab Daru-Iran) and in the second intervention group, 0.25 mg per cc of the drug Sufentanil (Daroopakhsh-Iran) mixed with 10 cc of Ropivacaine 0.1% (DarmanYab Daro-Iran) will be slowly injected by the anesthesiologist in the epidural space.
Main outcome variables
Duration of painlessness, headache, nausea and vomiting

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20220912055952N1
Registration date: 2022-09-24, 1401/07/02
Registration timing: prospective

Last update: 2022-09-24, 1401/07/02
Update count: 0
Registration date
2022-09-24, 1401/07/02
Registrant information
Name
Setayesh Hashemi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 86 3313 6055
Email address
setaayesh.hashemi@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-10-07, 1401/07/15
Expected recruitment end date
2022-11-21, 1401/08/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of adding sufentanil and dexamethasone to ropivacaine 0.1% in painless labor with epidural anesthesia
Public title
Comparison of adding sufentanil and dexamethasone to ropivacaine 0.1% in painless labor
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Term pregnancy Singleton pregnancy
Exclusion criteria:
Allergy to any of the drugs used The presence of spinal deformities Presence of coagulopathy History of heart/pulmonary/kidney/liver disease
Age
From 18 years old
Gender
Female
Phase
3
Groups that have been masked
  • Participant
  • Care provider
Sample size
Target sample size: 104
Randomization (investigator's opinion)
Randomized
Randomization description
In this study, we will use the restricted randomization method of the block randomization type. The size of all the blocks is equal and due to having two groups, there should be an equal number of states A and B in each block, which due to the volume of four blocks, there were six different states for the blocks, which are: AABB, ABAB, ABBA BBAA, BABA, BAAB. In order to conceal, we use allocation concealment, which refers to the method used to perform a random sequence on the participants in the study, so that the allocated group is not known before the allocation of the individual. The cards randomly and by re-replacing the selection and order of the blocks determine the order of placing the patients in groups A and B. A person who has no knowledge about the research will be used to select the cards on which the six states of blocks of four were written.
Blinding (investigator's opinion)
Double blinded
Blinding description
In this study, in order to observe the blinding of the patients, the anesthesiologist will completely randomly divide them into two groups receiving the mixture of ropivacaine and dexamethasone (group A) and the mixture of ropivacaine and fentanyl (group B). In both groups, the drugs used for the intervention are the same in terms of transparency and color, and the anesthesiologist has labeled each of them A and B. The syringes used are also the same shape, the same color, and completely similar, and to comply with blinding, the volume is 10 cc. It is delivered by the anesthesiologist in such a way that the anesthesiologist and patients and the intern responsible for data recording will not be able to identify the content of the solution from their appearance. The intern responsible for the project did not know the type of study groups from the beginning and is only responsible for filling out the questionnaires of the project and therefore the project will be implemented in a double-blind manner. In other words, the patient and the anesthesiologist responsible for drug injection and the intern responsible for data recording will be blind.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Arak University of Medical Sciences
Street address
Payambar azam complex, Basij Sq., Sardasht Town
City
Arak
Province
Markazi
Postal code
3848176341
Approval date
2022-07-03, 1401/04/12
Ethics committee reference number
IR.ARAKMU.REC.1401.105

Health conditions studied

1

Description of health condition studied
Painless labor
ICD-10 code
O80.0
ICD-10 code description
Spontaneous vertex delivery

Primary outcomes

1

Description
Duration of pain relief
Timepoint
At 15, 30 and 60 minutes after epidural injection
Method of measurement
Visual Analogue Scale of pain

Secondary outcomes

1

Description
Headache
Timepoint
Up to 6 hours after delivery
Method of measurement
Clinical interview

2

Description
Nausea
Timepoint
Up to 6 hours after delivery
Method of measurement
Clinical interview

Intervention groups

1

Description
The first intervention group: in 52 patients, 8 mg of dexamethasone (Alborz Daru-Iran) which was increased to 10 cc with 0.1% ropivacaine (Darmanyab Daru-Iran) will be slowly injecting by an anesthesiologist in the epidural space.
Category
Treatment - Drugs

2

Description
The second intervention group: in 52 patients, the amount of 0.25 mg per cc of sufentanil drug (Daru pakhsh-Iran) mixed with 10 cc of ropivacaine 0.1% (Darmanyab Daru-Iran) will be slowly injecting by an anesthesiologist in the epidural space.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Taleghani Hospital
Full name of responsible person
Setayesh Hashemi
Street address
Imam Khomeini Blvd.
City
Arak
Province
Markazi
Postal code
3816149369
Phone
+98 86 3277 6063
Email
It-taleghani@arakmu.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Arak University of Medical Sciences
Full name of responsible person
Alireza Kamali
Street address
Payambar azam complex, Basij Sq., Sardasht Town
City
Arak
Province
Markazi
Postal code
3848176341
Phone
+98 86 3417 3645
Email
research@arakmu.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Arak University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Arak University of Medical Sciences
Full name of responsible person
Setayesh Hashemi
Position
Student
Latest degree
A Level or less
Other areas of specialty/work
General Practitioner
Street address
Payambar azam complex, Basij Sq., Sardasht Town
City
Arak
Province
Markazi
Postal code
3848176341
Phone
+98 86 3417 3520
Email
Setaayesh.hashemi@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Arak University of Medical Sciences
Full name of responsible person
Setayesh Hashemi
Position
Student
Latest degree
A Level or less
Other areas of specialty/work
General Practitioner
Street address
Payambar azam complex, Basij Sq., Sardasht Town
City
Arak
Province
Markazi
Postal code
3848176341
Phone
+98 86 3417 3520
Email
Setaayesh.hashemi@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Arak University of Medical Sciences
Full name of responsible person
Setayesh Hashemi
Position
Student
Latest degree
A Level or less
Other areas of specialty/work
General Practitioner
Street address
Payambar azam complex, Basij Sq., Sardasht Town
City
Arak
Province
Markazi
Postal code
3848176341
Phone
+98 86 3417 3520
Email
Setaayesh.hashemi@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...